Impaired cardiopulmonary test performance as a marker of early functional impairment in patients with Anderson-Fabry disease
Published: 4 November 2021
Journal of Cardiovascular Medicine and Cardiology pp 069-071; https://doi.org/10.17352/2455-2976.000173
Abstract: Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disease characterized by progressive glicosphingolipid accumulation in multiple organs, due to α-galactosidase a deficiency . It is considered a rare disease although newborn genetic screening showed non-negligible prevalence (∼1:3.900) . Cardiac manifestations include progressive Left Ventricular (LV) Hypertrophy (LVH), which may be extreme and provoke both reduced stroke volume and dynamic LV outflow tract obstruction [2-6].
Keywords: impairment / extreme / functional / Anderson Fabry disease / glicosphingolipid accumulation
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Journal of Cardiovascular Medicine and Cardiology" .